accountThe decision requires Bayer to license the drug Nexavar to Natco Pharma, which must pay Bayer a royalty on its sales but will sell the drug for about 3 percent of Bayerâs price.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to India Orders Bayer to License Patented Cancer Drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account